Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health (ELV) and its ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The program now serves 6 million patients, and Elevance sees it as something that sets it apart from the competition.

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Elevance Health (ELV – Research Report) yesterday and set a price target of ...